Beta Drugs Ltd
NSE :BETA BSE :535022 Sector : PharmaceuticalsBuy, Sell or Hold BETA? Ask The Analyst
BSE
prev close
OPEN PRICE
volume
Today's low / high
52 WK low / high
bid price (qty)
offer price (qty)
NSE
prev close
open price
volume
Today's' low / high
52 WK low / high
bid price (qty)
offer price (qty)
25 Mar 1842.86 (-2.53%) | 24 Mar 1890.76 (3.13%) | 21 Mar 1833.38 (4.06%) | 20 Mar 1761.90 (-1.14%) | 19 Mar 1782.24 (3.39%) | 18 Mar 1723.76 (3.08%) | 17 Mar 1672.19 (2.90%) | 13 Mar 1625.14 (2.63%) | 12 Mar 1583.52 (-1.62%) | 11 Mar 1609.52 (-0.36%) | 10 Mar 1615.38 (-1.16%) | 07 Mar 1634.38 (-5.57%) | 06 Mar 1730.81 (2.21%) | 05 Mar 1693.33 (10.83%) | 04 Mar 1527.86 (0.58%) | 03 Mar 1519.05 (-3.30%) | 28 Feb 1570.86 (0.02%) | 27 Feb 1570.47 (-0.66%) | 25 Feb 1580.95 (1.03%) | 24 Feb 1564.76 (-0.38%) | 21 Feb 1570.76 (-4.57%) |
Technical Analysis
Short Term Investors

Very Bullish
Medium Term Investors

Neutral
Long Term Investors

Very Bullish
Moving Averages
5 DMA
Bullish
1822.23
10 DMA
Bullish
1732.53
20 DMA
Bullish
1666.66
50 DMA
Bullish
1720.79
100 DMA
Bearish
1852.26
200 DMA
Bullish
1635.29
Intraday Support and Resistance
(Based on Pivot Points) undefined |
Updated On Mar 25, 2025 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 1961.9 | 1938.09 | 1862.5 | - | - |
R2 | 1938.09 | 1910.81 | 1855.95 | 1932.14 | - |
R1 | 1890.48 | 1893.95 | 1849.41 | 1878.58 | 1914.28 |
P | 1866.67 | 1866.67 | 1866.67 | 1860.72 | 1878.57 |
S1 | 1819.06 | 1839.39 | 1836.31 | 1807.16 | 1842.86 |
S2 | 1795.25 | 1822.53 | 1829.77 | 1789.3 | - |
S3 | 1747.64 | 1795.25 | 1823.22 | - | - |
Key Metrics
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Beta Drugs Ltd Quaterly Results
INCOME | |
PROFIT | |
EPS |
Beta Drugs Ltd Quaterly Results
INCOME | |
PROFIT | |
EPS |
Profit & Loss (Figures in Rs. Crores)
Beta Drugs Ltd Profit & Loss
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 51.49 | 69.97 | 92.07 | 118.39 | 186.35 | 232.57 | 315.31 | |
PROFIT | 6.76 | 8.04 | 9.44 | 11.72 | 24.83 | 30.72 | 36.44 | |
EPS | 7.82 | 9.3 | 9.79 | 12.2 | 25.82 | 31.95 | 37.9 |
Beta Drugs Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 0.37 | 26.6 | 41.22 | 51.49 | 61.04 | 65.54 | 81.45 | 124.85 | 162.08 | 206.33 | |
PROFIT | -0.11 | 1.13 | 4.27 | 6.76 | 7.71 | 7.1 | 6.98 | 14.25 | 18.82 | 21.94 | |
EPS | 0 | 11.23 | 42.27 | 7.82 | 8.92 | 7.39 | 7.26 | 14.82 | 19.57 | 22.82 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
SOURCES OF FUNDS : | |||||||
Share Capital | 9.61 | 9.61 | 9.61 | 9.61 | 9.61 | 8.65 | 8.65 |
Reserves Total | 147.5 | 113.27 | 82.73 | 59 | 47.5 | 32.27 | 24.23 |
Total Shareholders Funds | 157.11 | 122.88 | 92.34 | 68.61 | 57.11 | 40.92 | 32.88 |
Secured Loans | 14.53 | 20.33 | 20.6 | 17.46 | 22.54 | 19.97 | 7.5 |
Unsecured Loans | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 |
Total Debt | 14.53 | 20.33 | 20.6 | 17.46 | 22.57 | 19.97 | 7.5 |
Other Liabilities | 6.27 | 5.55 | 4.71 | 4.46 | 3.1 | 2.27 | 0.43 |
Total Liabilities | 177.91 | 148.76 | 117.65 | 90.53 | 82.78 | 63.16 | 40.81 |
APPLICATION OF FUNDS : | |||||||
Gross Block | 109.49 | 99.37 | 82.17 | 61.14 | 58.29 | 25.38 | 18.06 |
Less: Accumulated Depreciation | 44.9 | 36.61 | 27.22 | 21.17 | 14.46 | 7.71 | 4.87 |
Net Block | 64.59 | 62.76 | 54.95 | 39.97 | 43.83 | 17.67 | 13.19 |
Capital Work in Progress | 0 | 0 | 0 | 2.81 | 0.08 | 14.69 | 1.35 |
Investments | 0 | 0.78 | 0.78 | 0.78 | 0.35 | 0.35 | 0 |
Inventories | 49.81 | 30.62 | 22.48 | 16.04 | 12.35 | 9.53 | 2.8 |
Sundry Debtors | 79.24 | 62.72 | 45.18 | 33.88 | 31.93 | 25.03 | 14.44 |
Cash and Bank Balance | 28.63 | 19.16 | 17.32 | 10.42 | 5.39 | 3.3 | 11.91 |
Loans and Advances | 20.18 | 15.18 | 11.97 | 7.7 | 6.37 | 5.09 | 3.17 |
Total Current Assets | 177.87 | 127.69 | 96.96 | 68.04 | 56.04 | 42.95 | 32.32 |
Current Liabilities | 73.38 | 45.49 | 36.56 | 25.55 | 23.19 | 18.64 | 8.3 |
Provisions | 2.8 | 4.17 | 3.63 | 1.42 | 1.2 | 0.74 | 0.33 |
Total Current Liabilities & Provisions | 76.18 | 49.66 | 40.19 | 26.96 | 24.4 | 19.38 | 8.63 |
Net Current Assets | 101.69 | 78.03 | 56.77 | 41.07 | 31.64 | 23.57 | 23.7 |
Deferred Tax Assets | 1.41 | 1.2 | 0.68 | 0.65 | 0.17 | 0.29 | 0 |
Deferred Tax Liability | 0 | 0 | 0 | 0 | 0 | 0.15 | 0.15 |
Net Deferred Tax | 1.41 | 1.2 | 0.68 | 0.65 | 0.17 | 0.14 | -0.15 |
Other Assets | 10.23 | 6 | 4.48 | 5.26 | 6.72 | 6.74 | 2.72 |
Total Assets | 177.92 | 148.77 | 117.67 | 90.54 | 82.78 | 63.16 | 40.8 |
Contingent Liabilities | 1.55 | 1.55 | 0 | 0 | 0.73 | 0 | 0 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 9.61 | 9.61 | 9.61 | 9.61 | 9.61 | 8.65 | 8.65 | 1.01 | 1.01 | 1.01 |
Reserves Total | 106.4 | 86.64 | 67.85 | 53.8 | 46.83 | 31.95 | 24.23 | 5.06 | 1.19 | 0.06 |
Total Shareholders Funds | 116.01 | 96.25 | 77.46 | 63.41 | 56.44 | 40.6 | 32.88 | 6.07 | 2.2 | 1.07 |
Secured Loans | 5.68 | 5.95 | 6.84 | 5.19 | 8.88 | 6.09 | 7.5 | 5.85 | 5.37 | 1.99 |
Unsecured Loans | 0 | 0 | 0 | 0 | 0.03 | 1.79 | 0 | 2.36 | 2.97 | 2.78 |
Total Debt | 5.68 | 5.95 | 6.84 | 5.19 | 8.91 | 7.88 | 7.5 | 8.21 | 8.34 | 4.77 |
Other Liabilities | 3.18 | 2.59 | 2.44 | 1.82 | 0.86 | 0.58 | 0.43 | 0.25 | 0.06 | 0 |
Total Liabilities | 124.87 | 104.79 | 86.74 | 70.42 | 66.21 | 49.06 | 40.81 | 14.53 | 10.6 | 5.84 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 65.12 | 59.84 | 53.86 | 43.15 | 41.54 | 19.41 | 18.06 | 11.12 | 9.1 | 1.07 |
Less : Accumulated Depreciation | 28.64 | 25.07 | 19.81 | 15.14 | 9.87 | 7.29 | 4.87 | 3.02 | 1.76 | 0.52 |
Net Block | 36.48 | 34.77 | 34.05 | 28.01 | 31.67 | 12.12 | 13.19 | 8.1 | 7.34 | 0.55 |
Capital Work in Progress | 0 | 0 | 0 | 1.9 | 0.08 | 14.69 | 1.35 | 0 | 0 | 5.71 |
Investments | 5.77 | 6.55 | 6.54 | 6.54 | 6.12 | 1.61 | 0 | 0 | 0 | 0 |
Inventories | 21.94 | 13.66 | 8.47 | 7.7 | 6.1 | 6.41 | 2.8 | 2.4 | 2.86 | 1.28 |
Sundry Debtors | 50.49 | 43.59 | 31.35 | 20.81 | 20.91 | 17.33 | 14.44 | 10.51 | 4.4 | 0.08 |
Cash and Bank Balance | 27.2 | 17.79 | 15.58 | 8.27 | 4.16 | 2.92 | 11.91 | 0.14 | 0.13 | 0.06 |
Loans and Advances | 14.05 | 9.95 | 7.35 | 6.78 | 6 | 4.73 | 3.17 | 2.05 | 0.41 | 0.27 |
Total Current Assets | 113.68 | 85 | 62.76 | 43.55 | 37.17 | 31.39 | 32.32 | 15.11 | 7.8 | 1.69 |
Current Liabilities | 43.74 | 26.31 | 22.22 | 15.23 | 15.42 | 15.01 | 8.3 | 7.74 | 4.57 | 2.17 |
Provisions | 1.87 | 2.94 | 1.94 | 0.57 | 0.56 | 0.58 | 0.33 | 0.86 | 0.03 | 0 |
Total Current Liabilities & Provisions | 45.61 | 29.25 | 24.16 | 15.81 | 15.98 | 15.59 | 8.63 | 8.6 | 4.6 | 2.17 |
Net Current Assets | 68.07 | 55.75 | 38.6 | 27.74 | 21.19 | 15.8 | 23.7 | 6.5 | 3.2 | -0.48 |
Deferred Tax Assets | 0.81 | 0.89 | 0.6 | 0.37 | 0 | 0.25 | 0 | 0 | 0 | 0 |
Deferred Tax Liability | 0 | 0 | 0 | 0 | 0.03 | 0.15 | 0.15 | 0.08 | 0 | 0 |
Net Deferred Tax | 0.81 | 0.89 | 0.6 | 0.37 | -0.03 | 0.1 | -0.15 | -0.08 | 0 | 0 |
Other Assets | 13.73 | 6.83 | 6.94 | 5.86 | 7.18 | 4.74 | 2.72 | 0 | 0.07 | 0.07 |
Total Assets | 124.86 | 104.79 | 86.74 | 70.42 | 66.21 | 49.06 | 40.8 | 14.53 | 10.61 | 5.84 |
Contingent Liabilities | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 48.75 |
Depreciation | 9.78 |
Interest (Net) | 1.74 |
Total Adjustments (PBT and Ext... | -4.25 |
Operating Profit before Workin... | 44.51 |
Trade and 0ther Receivables | -16.52 |
Inventories | -19.19 |
Trade Payables | 19.03 |
Loans and Advances | -1.06 |
Total Adjustments (OP before W... | -13.58 |
Cash Generated from/(used in) ... | 30.93 |
Cash Flow before Extraordinary... | 30.93 |
Net Cash from Operating Activi... | 30.93 |
Purchased of Fixed Assets | -11.62 |
Sale of Investments | 0.78 |
Interest Received | 1.08 |
Net Cash used in Investing Act... | -13.97 |
Of the Long Tem Borrowings | -0.56 |
Of the Short Term Borrowings | -4.11 |
Interest Paid | -2.82 |
Net Cash used in Financing Act... | -7.49 |
Net Profit before Tax and Extr... | 29.48 |
Depreciation | 4.72 |
Interest (Net) | -0.49 |
Total Adjustments (PBT and Ext... | -6.29 |
Operating Profit before Workin... | 23.19 |
Trade and 0ther Receivables | -6.9 |
Inventories | -8.27 |
Trade Payables | 12.59 |
Loans and Advances | -0.99 |
Total Adjustments (OP before W... | -2.01 |
Cash Generated from/(used in) ... | 21.19 |
Cash Flow before Extraordinary... | 21.19 |
Net Cash from Operating Activi... | 21.19 |
Purchased of Fixed Assets | -6.43 |
Sale of Investments | 0.78 |
Interest Received | 1.54 |
Net Cash used in Investing Act... | -11.02 |
Proceed from 0ther Long Term B... | 0.29 |
Interest Paid | -1.05 |
Net Cash used in Financing Act... | -0.76 |
Company Details
Registered Office |
|
Address | Village Nandpur, |
City | Baddi |
State | Himachal Pradesh |
Pin Code | 174101 |
Tel. No. | 91-1795-236196 |
Fax. No. | |
info@betadrugslimited.com | |
Internet | http://www.betadrugslimited.com |
Registrars |
|
Address | Village Nandpur |
City | Baddi |
State | Himachal Pradesh |
Pin Code | 174101 |
Tel. No. | 91-1795-236196 |
Fax. No. | |
info@betadrugslimited.com | |
Internet | http://www.betadrugslimited.com |
Management |
|
Name | Designation |
Balwant Singh. | Whole-time Director |
Varun Batra | Joint Managing Director |
Rahul Batra | Chairperson & M D |
Manmohan Khanna | Independent Director |
Rohit Parti | Independent Director |
Rajni Brar | Company Sec. & Compli. Officer |
Seema Chopra | Whole-time Director |
Ashutosh Shukla | Whole-time Director |